Table 2. Clinical characteristics of the study population.
Statistically significant P-value ≤0.05 IFG, impaired fasting glucose; T2DM, people with type 2 diabetes; ND, non-diabetics (healthy); BMI, body mass index; WC, waist circumference; HC, hip circumference; HDL, High- Density Lipoprotein; LDL, Low-Density Lipoprotein; TC, Total Cholesterol; TG, triglyceride; FBG, fasting blood sugar; IFG/T2DM, impaired fasting glucose/type 2 diabetics; ND, non-diabetic.
| Variable | IFGT2DM (n=80) | ND | P-value |
|---|---|---|---|
| Age (years) | 52.9±13.1 | 36.9 ±11.7 | <0.001 |
| BMI (kg/m2) | 27.4 (24.8–29.8) | 24.2 (21.5–27.3) | <0.001* |
| WC (cm) | 96.3±12.6 | 103.1±13.1 | 0.006* |
| HC (cm) | 105.2±14.6 | 96.9±15.7 | 0.004* |
| HDL (mmol/L) | 1.19 (0.88–1.40) | 1.21 (1.09–1.47) | 0.232 |
| LDL (mmol/L) | 2.98±1.09 | 2.70±0/60 | 0.143 |
| TG (mmol/L) | 1.56 (1.11–2.28) | 2.28 (0.94–1.82) | 0.012* |
| TC (mmol/L) | 4.78±1.27 | 4.31±1.04 | 0.055 |
| FBG (mmol/L) | 8.10 (6.83–9.99) | 4.91 (4.55–5.22) | <0.001* |
| Insulin (pmol/L) | 65.98 (42.36–106.26) | 58.34 (38.20–96.53) | 0.219 |
| Vaspin (ng/mL) | 0.98 (0.77–1.15) | 1.43 (0.90–1.62) | <0.001* |